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Abstract
Background Although malnutrition and sarcopenia are prevalent in cirrhosis, their impact on outcomes following liver trans-
plantation is not well documented.
Methods The associations of nutritional status and sarcopenia with post-transplant infections, requirement for mechanical
ventilation, intensive care (ICU) and hospital stay, and 1 year mortality were assessed in 232 consecutive transplant recipi-
ents. Nutritional status and sarcopenia were assessed using the Royal Free Hospital-Global Assessment (RFH-GA) tool and
the L3-psoas muscle index (L3-PMI) on CT, respectively.
Results A wide range of RFH-SGA and L3-PMI were observed within similar Model for End-stage Liver Disease (MELD) sub-
categories. Malnutrition and sarcopenia were independent predictors of all outcomes. Post-transplant infections were associated
withMELD (OR=1.055, 95%CI = 1.002–1.11) and severemalnutrition (OR=6.55, 95%CI = 1.99–21.5); ventilation> 24h withMELD
(OR=1.1, 95%CI = 1.036–1.168), severe malnutrition (OR=8.5, 95%CI = 1.48–48.87) and suboptimal donor liver (OR=2.326, 95%
CI = 1.056–5.12); ICU stay> 5days, with age (OR=1.054, 95%CI = 1.004–1.106), MELD (OR=1.137, 95%CI = 1.057–1.223) and
severe malnutrition (OR=7.46, 95%CI = 1.57–35.43); hospital stay> 20days with male sex (OR=2.107, 95%CI = 1.004–4.419)
and L3-PMI (OR=0.996, 95%CI = 0.994–0.999); 1 year mortality with L3-PMI (OR=0.996, 95%CI = 0.992–0.999). Patients at the
lowest L3-PMI receiving suboptimal grafts had longer ICU/hospital stay and higher incidence of infections.
Conclusions Malnutrition and sarcopenia are associated with early post-liver transplant morbidity/mortality. Allocation
indices do not include nutritional status and may jeopardize outcomes in nutritionally compromised individuals.
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Introduction
Malnutrition is a common complication of end-stage liver
disease.1 It adversely affects health-related quality of life, is
associated with an increased risk for developing the compli-
cations of cirrhosis, including hepatic encephalopathy, and
has detrimental effects on outcome following liver transplan-
tation and survival.2 The deterioration of nutritional status in
end-stage liver disease is multifactorial and includes inade-
quate dietary intake because of nausea or vomiting, dietary
restriction of salt and proteins, anorexia, presence of ascites
and/or encephalopathy, malabsorption because of pancreatic
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insufﬁciency, small bowel bacterial overgrowth or cholestasis,
side-effects of drug therapy, or liver disease-related meta-
bolic disturbances.3 Sarcopenia is not synonymous with mal-
nutrition although there is an important overlap among
them.4 In a cohort of 300 patients with cirrhosis, malnutrition
was prevalent in 75% and increased from 46% to 84% and
95% across Child–Pugh A, B, and C stages.5 Patients with mal-
nutrition and/or sarcopenia have longer hospital stay, in-
creased incidence of ascites and hepatorenal syndrome, and
increased in-hospital mortality.6,7
Despite its high signiﬁcance, assessment of nutritional
status in cirrhosis is often neglected. In a nationwide
study,6 only 6% of patients with cirrhosis who were admit-
ted to hospital were diagnosed with malnutrition compared
with 2% of the general admissions, implying that nutritional
assessment is often overlooked; thus, its prevalence could
be even higher than reported. Various indexes and methods
have been proposed to evaluate nutrition in end-stage liver
disease with diverse results among them.8,9 Usual markers
of body composition, such as body mass index (BMI), skin
fold thickness, or bioelectrical impendance, are limited by
the lack of availability and/or reproducibility, inter-observer
variability, or decreased accuracy because of ﬂuid retention
in cirrhosis.9,10 The Royal Free Hospital-Global Assessment
(RFH-GA) is a subjective index for nutritional assessment
which combines BMI, triceps skin fold thickness, and mid-
arm muscle circumference (MAMC) with dietary intake.11
It therefore incorporates both malnutrition and sarcopenia
in an easily reproducible score. In a cohort of 222 patients
with cirrhosis, RFH-GA was independently associated with
mortality with a relative hazard ratio of 5.26 for severely
malnourished patients.12 One-year mortality in well
nourished, mildly/moderately malnourished, and severely
malnourished patients was 5%, 20%, and 35%, respectively,
in this cohort.12
CT scan and MRI are considered the gold standards to as-
sess skeletal muscle mass and to detect sarcopenia.13,14
Sarcopenia estimated by cross-sectional area of psoas or
other muscles at the level of third or fourth lumbar vertebrae
(L3 or L4) has been associated with overall mortality in patients
with cirrhosis,15,16 waiting-list mortality,17 post-transplant se-
vere infections or sepsis,18 and longer post-operative hospital
stay.19 Considering that prolonged mechanical ventilation and
intensive care unit (ICU) stay, bacterial infections, and
prolonged hospital stay are well-validated negative predictors
for post-liver transplant (LT) survival,20 the impact of malnutri-
tion and muscle depletion on these variables is pivotal.
The aim of the study was to assess the prevalence and
determine the predictors of sarcopenia and malnutrition
in a consecutive cohort of transplanted patients and to
further evaluate their effect on relevant post-LT outcomes
including occurrence of infections, duration of mechanical
ventilation, length of ICU and hospital stay, and 1 year
mortality.
Patients and methods
Study population
The study comprised of 232 consecutive patients with cirrho-
sis who were transplanted at the Royal Free Hospital
between January 2008 and December 2012 and fulﬁlled the
inclusion criteria. These patients were selected from a cohort
of 329 liver transplant recipients between 2008 and 2012.
Patients with CT scan date >12weeks pre-LT or >1week
post-LT (n = 39), unavailable CT scan at the third lumbar (L3)
section (n = 12), acute liver failure (n = 44), or previous LT
(n = 2), were excluded from the analysis. In the UK, initial
transplant eligibility is based on a minimum UKELD score,
which is different than the Model for End-stage Liver Disease
(MELD) score in the sense that it also incorporates sodium
and is calibrated to predict 12month rather than 3month
survival.21 Moreover, the allocation system is centre based
rather than patient based, i.e. the graft goes to a speciﬁc
transplant centre that then decides on allocation rather than
to a speciﬁc patient based on a prioritization score.
Clinical and laboratory data
All data were recovered retrospectively from the institutions
electronic database, medical ﬁles (hard copies) and clinical
correspondence. ICU data and outcomes were collected for
every patient. The data collected included recipient age and
gender, donor age and gender, cold ischemia time (CIT),
donor liver appearance (steatotic or non-steatotic), type of
donor graft [donation before or after cardiac death (DCD)],
ethnicity, indication for LT, nutritional assessment and anthro-
pometric characteristics, laboratory investigations, presence
of ascites or encephalopathy, and dates of LT and CT scan.
Marginal liver grafts were deﬁned as grafts with steatotic ap-
pearance and a CIT> 12 h. The primary outcomes were the
duration of mechanical ventilation, the length of ICU and hos-
pital stay, the development of in-hospital infections, and the
12month mortality following LT. The diagnosis of presence
and type of infection was based on internationally accepted
Center for Disease Control (CDC) criteria.22 The severity of
liver disease was assessed by the Child–Pugh score and the
MELD within 1week from the CT scan used to determine
psoas muscle measurements.
Nutritional assessment
A detailed nutritional assessment was performed by a spe-
cialist liver transplant dietitian (SA) as part of the routine pa-
tients’ pre-LT assessment.11 The assessment was conducted
using the Royal Free Hospital Global Assessment (RFH-GA)
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which comprises of a mixture of subjective and objective,
anthropometric variables. It has been validated for use
against the four-component mode.11
The RFH-GA provides a validated assessment of nutritional
status and is accepted as the gold standard for nutritional as-
sessment of liver disease patients in the UK. All eight liver
transplant units in the UK and Southern Ireland use this tool
for the assessment of patient being considered for a liver
transplant. In-depth questioning was undertaken to obtain
the information needed for completion of the subjective
component of the RFH-GA. Full details about the RFH-GA tool
are provided in the Web Appendix.
The anthropometric measurements were undertaken using
a standard protocol and collection instruments as outlined
below. Measurements were undertaken on the non-
dominant arm using the writing hand to deﬁne dominance
unless anatomical abnormalities or the siting of intravenous
infusions precluded access.
Mid arm circumference was measured using a tape mea-
sure (Holtain Ltd, Crymych, Dyfed, UK) between the acromial
process of the scapular and the olecranon process of the
elbow using the Parenteral and Enteral Group of the British
dietetic association (PENG) method. The triceps skinfold thick-
ness (TSF) was measured to 0.2mm using Holtain/Tanner-
Whitehouse skinfold calipers measured in triplicate at the site
of the MAC measurement and the mean calculated. Measures
of MAC and TSF below the 5th percentile are indicative of
malnutrition. These two measurements are used to calculate
MAMC:
MAMC cmð Þ ¼ MAC cmð Þ– 3:14TSF cmð Þ½ :
Data compared with published standards and expressed in
relation to percentiles for the appropriate age and gender
categories. Hand grip strength was measured in kilogramme
on the non-dominant hand using Takei A5401 digital hand
grip dynamometer and compared with the references ranges
set by Goode et al and Klidjian et al by age and gender. Height
was measured to the nearest centimetre using a wall mounted
or frees standing measure (Seca, Hamberg, Germany). Current
weight was recorded to the nearest 0.1kg using a weighing
(Seca) or seat balance scale (Marsden W/M Group, London,
UK). Dry body weight was estimated using published suggested
adjustment for the degree of ﬂuid retention, if appropriate,
together with dietetic clinical judgement and a dry BMI
estimated.23 The overall adequacy of the diet in relation to
estimated requirements assessed using Schoﬁeld’s modiﬁcation
of the Harris–Benedict equations was estimated and catego-
rized as adequate, if it met estimated requirements, inade-
quate, if it failed to meet estimated requirements but
exceeded 500 kcal/day, or negligible if it provided less than
500 kcal daily.
The collected data on BMI, MAMC, and dietary intake were
then utilized to categorize nutritional status as per the
construct algorithm (Appendix). In a minority of cases, a sub-
jective override was applied as previously described to allow
the assessor to change the nutritional category by a single
grading if warranted on clinical grounds.11 This override could
be used, for example, to reclassify an individual who reported
profound recent weight loss yet still maintained a BMI above
20 kg/m2 from adequately nourished to moderately malnour-
ished. Patients’ nutritional status was ﬁnally categorized as
adequate/unimpaired, moderately malnourished or at risk
of malnutrition, or severely malnourished.11
Sarcopenia assessment by CT scanning
CT scans were performed as part of the LT assessment or dic-
tated from acute medical conditions. Scans were acceptable if
performed up to 12weeks prior to LT or within a week post LT
and if sections included the L3 vertebrae. A word document
was kept that recorded all issues towards technique’s stan-
dardization. Transverse CT sections were analysed at the third
lumbar level (L3). Total psoas muscle area (TPA) was measured
as previously described.24 The psoas muscle was selected from
other skeletal muscles of the region because it is located cen-
trally, is easily identiﬁed and is not directly affected by abdom-
inal distension in the presence of ascites.25,26 All CT images
were analysed by a dedicated radiologist.27 Cross-sectional
psoas muscle area was normalized for stature and the L3-psoas
muscle index (L3-PMI) was deﬁned as psoas muscle
area/height2 (mm/m2). Patients were grouped into sex-
stratiﬁed L3-PMI quartiles to avoid the well-documented sex
inﬂuence on muscle mass. Patients in the lowest sex-stratiﬁed
L3-PMI quartiles were deemed as sarcopenic.
Statistical analysis
Numerical data were expressed as mean ± standard deviation
if the distribution was normal or median with interquartile
range if not, and categorical data as frequencies. All variables
were tested for normal distribution using the Kolmogorov–
Smirnov test. In univariate analysis, categorical variables were
tested using the chi-square and Fisher’s exact test. Continu-
ous variables with and without normal distribution were
compared using Student’s t-test or the Mann–Whitney U test,
respectively. Correlations between continuous variables were
tested using the Spearman correlation coefﬁcient (r) analysis.
Variables signiﬁcant at the 0.1 level were included in the mul-
tivariate analysis. Multivariate ordinal regression analysis was
used to deﬁne predictors of malnutrition based on RFH-GA.
Multivariate binary logistic regression analysis was used to
determine independent predictors for the lowest quartile of
L3-PMI and to deﬁne the predictive factors for post-LT infec-
tions, mechanical ventilation> 24 h, ICU stay> 5 days, and
hospital stay> 20 days. Collinearity between RFH-GA and
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L3-PMI was tested using the tolerance and VIF measure in the
multivariate models; no collinearity was observed. The follow-
ing variables were considered for possible inclusion in the mul-
tivariate regression model and were tested using univariate
analysis: height, dry weight, BMI, MAC, MAMC, TSF, HGS, die-
tary intake, RFH-GA, recipient age and gender, donor age and
gender, smoking, CIT, donor liver appearance, type of donor
graft, ethnicity, indication for LT, hepatocellular carcinoma,
presence of ascites and encephalopathy, MELD score, and
L3-PMI. Univariate and multivariate Cox regression analysis
was used to deﬁne independent predictor for 12month
mortality post liver transplantation. All statistical tests were
two sided. The SPSS statistical package (version 22.0, IBM,
New York, NY, USA) was used.
Results
Baseline clinical and biochemical characteristics
Baseline characteristics of the included patients are shown in
Table 1. Mean age was 53 (22–70) years and 162 (69.8%)
were males. The main indication for liver transplantation
was chronic hepatitis C (n = 68, 29.3%) followed by alcoholic
liver disease (n = 55, 23.7%), primary sclerosing cholangitis
(n = 29, 12.5%) and primary biliary cirrhosis (n = 17, 7.3%).
All CT scans were performed at a median of 10.6 (12 to 1)
weeks before LT. The lowest L3-PMI quartile cut-off was
340mm2/m2 for men (n = 40, 24.7%) and 264mm2/m2
(n = 17, 24.3%) for women. Approximately 38% of the donors
were older than 50 years. Sex mismatch between liver recip-
ients and donors was present in 120 cases (51.7%). Among the
64 suboptimal donor livers, 90.6% (n = 58) had steatosis on vi-
sual inspection (48.4% mild, 40.6% moderate, 1.6% severe),
3.1% (n = 2) were liver size-mismatched, and 6.3% (n = 4)
had liver trauma. At 1 year post-LT, 216 (93%) of patients
were alive. All alive patients were back to a normal nutri-
tional status within 6–9months after their transplant. In
contrast, in 35 patients on the transplant waiting list that
were seen at least twice by a dedicated dietitian within
6months, the nutritional status did not change despite
targeted interventions.
Correlation of L3-psoas muscle index (L3-PMI) with
baseline characteristics
Males had signiﬁcantly higher L3-PMI compared with female
patients (P< 0.001). L3-PMI was positively correlated with
dry weight (r = 0.403, P< 0.001), BMI (r = 0.34, P< 0.001),
MAC (r = 0.396, P< 0.001), MAMC (r = 0.385, P< 0.001),
triceps skin fold thickness (r = 0.164, P = 0.03), handgrip
strength (r = 0.382, P< 0.001), RFH-GA (P< 0.001), and MELD
(r =0.18, P = 0.007). Figure 1 shows a wide range of L3-PMI
across the different sub-categories of RFH-GA. There was also
a wide variation and overlap of L3-PMI across similar MELD
scores (Figure 2). In the multivariate binary logistic regression
analysis, independent predictors for sarcopenia, deﬁned as
the lowest quartile of L3-PMI, were severe malnutrition [odds
ratio (OR): 6.56, 95%CI 1.76–24.4] and handgrip strength
(OR: 1.067, 95%CI 1.02–1.117). The baseline characteristics
and outcomes of patients are shown in Table 1.
Correlation of Royal Free Hospital-Global
Assessment with baseline characteristics
Moderate/severe malnutrition as indicated by a RFH-GA
score of 2 or 3 was independently associated with male sex
(OR = 3.76, 95% CI: 1.787–7.913), younger age (OR = 0.953,
95% CI: 0.924–0.983) and lower L3-PMI (OR = 0.993, 95% CI:
0.991–0.996). Severe malnutrition was independently associ-
ated with age (OR: 0.914, 95% CI: 0.87–0.96) and L3-PMI (OR:
0.989–0.999), but not with male sex. RFH-GA was not associated
with the MELD score. Figure 3 demonstrates the distribution
rates of the well-nourished, mild/moderately malnourished and
severely malnourished patients (assessed with RFH-SGA) in dif-
ferent sub-categories of the MELD score.
Predictors of post-LT outcomes
(i) In-hospital infections: Post-LT infections were docu-
mented in 76 (32.8%) patients. The rates of fungal infec-
tions, bacteremia, chest, urinary tract, and abdominal
infections during hospitalization were 5.2% (n = 12),
15.1% (n = 35), 13.8% (n = 32), 15.9% (n = 37), and
16.4% (n = 38), respectively. There was no association of
L3-PMI with the type of infection. However, a signiﬁcant
positive correlation was observed between overall post-
LT infections and RFH-GA as well as with the MELD score.
In multivariate binary regression analysis, severe malnu-
trition (RFH-GA score 3: OR = 6.55, 95%CI = 1.99–21.5)
and MELD (OR = 1.055, 95%CI = 1.002–1.11) were inde-
pendent predictors of post-LT infections.
(ii) Mechanical ventilation duration >24 h: The median
duration of mechanical ventilation post-LT was 21
(1–1920) h. Eighty four patients (36.2%) required mechan-
ical ventilation for more than 24h. In multivariate analysis,
MV for >24h was independently associated with MELD
(OR=1.1, 95%CI =1.036–1.168), severe malnutrition
(RFH-GA score 3: OR=8.5, 95%CI =1.48–48.87) and subop-
timal donor liver (OR=2.326, 95%CI = 1.056–5.12).
(iii) ICU stay >5 days: The median duration of ICU stay was
3 (0–88) days. Forty-eight patients (20.7%) required an
ICU stay of >5days. In multivariate binary logistic regres-
sion analysis, MELD score (OR: 1.137, 95%CI: 1.057–1.223),
age (OR=1.054, 95%CI =1.004–1.106) and severe
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malnutrition (RFH-GA score 3: OR=7.46, 95%CI=1.57–35.43)
were independently associated with ICU stay of more than
5days.
(iv) Hospital stay >20 days: The median hospital stay was
22 (11–389) days. One-hundred thirty-two patients
(56.9%) required a hospital stay of >20 days. In multi-
variate binary regression analysis, male sex (OR = 2.107,
95%CI = 1.004–4.419) and L3-PMI (OR = 0.996, 95%
CI = 0.994–0.999) were independent predictors for a
hospital stay >20 days.
(v) 12month mortality: Sixteen (6.9%) patients died within
12months post-transplant. In multivariate Cox regression
analysis including age, sex, L3-PMI and RFH-GA as
co-factors, only low L3-PMI was signiﬁcantly associated
with higher 12month mortality risk (OR=0.996, 95%
CI = 0.992–0.999). The median L3-PMI between survivors
and non-survivors was 410.1 vs. 337.2mm2/m2, respec-
tively. Malnourishment, assessed with RFH-GA score, and
MELD score were not found signiﬁcant.
The univariate and multivariate analyses of the post-LT out-
comes of interest are shown in Supplementary Table 1 and
Table 2, respectively.
Sarcopenia and malnutrition in patients receiving
marginal grafts
In the subgroup analysis of patients that received a marginal
graft (n = 10), the median MV duration was 28.5 (4–1920) h
Table 1 Characteristics of liver transplant recipients at the time of waiting list registration, statistics for selected donor and transplant parameters and
for outcomes of interest in the total study population
Recipient factors Total population
Age (years), median (range) 54 (22–70)
Sex (M/F), n (%) 162/70 (69.8/30.2)
Ethnicity, n (%)(Caucasian/African/Asian/Other) 177/13/39/3 (76.3/5.6/16.8/1.3)
Height (cm), median (range) 172 (150–200)
Dry weight (kg), median (range) 74 (44–150)
BMI (kg/m2), median (range) 25 (16–41.7)
MAC (cm), median (range) 28.5 (18–46)
MAMC (cm), median (range) 26 (16–50.6)
TSF (mm), median (range) 14 (2–72)
HGS (kg), median (range) 25.6 (1–79)
RFH-GA, n (%) Well-nourished 94 (53.4)
Mild/Moderately malnourished 67 (38.1)
Severely malnourished 15 (8.5)
Cause of liver disease, n (%)(autoimmunea/viral/alcohol/other) 47/81/55/49 (20.3/34.9/23.7/21.1)
Hepatocellular carcinoma, n (%) 58 (25)
MELD score, median (range) 14 (6–42)
CP score, median (range) 8 (5–15)
CP class (A/B/C), n (%) 59/111/62 (25.4/47.8/26.7)
Ascites, n (%) 115 (49.6)
L3 PMI (mm2/m2), median (range) Total 406.3 (78.9–983)
Males 428.8 (162.5–983)
Females 352.4 (78.9–763.8)
Lowest L3-PMI, n (%) 57 (24.6%)
Donor factors
Age (years), median (range) 47.5 (13–80)
Sex (M/F), n (%) 113/119 (48.7/51.3)
DCD, n (%) 35 (15)
Transplant factors
Suboptimal liver appearance, n (%) 64 (27.6)
CID (min), median (range) 473.5 (42–1057)
Outcomes
In-hospital infections, n (%) 76 (32.8)
MV duration (h), median (range) 21 (0–1920)
MV duration >24 h, n (%) 84 (36.2)
ICU stay (days), median (range) 3 (0–88)
ICU stay >5 days, n (%) 48 (20.7)
Hospital stay (days), median (range) 22 (11–389)
Hospital stay >20 days, n (%) 132 (56.9)
12month mortality, n (%) 16 (6.9%)
BMI, body mass index; CID, cold ischemia time; CP, Child–Pugh; DCD, donation after cardiac death; HCC, hepatocellular carcinoma; HGS,
hand grip strength; ICU, intensive care unit; MAC, mid arm circumference; MAMC, mid arm muscle circumference; MELD, Model for End-
stage Liver Disease; M/F, males/females; MV, mechanical ventilation; PMI, psoas muscle index; RFH-GA, Royal Free Hospital Global Assess-
ment; TSF, triceps skin fold.
aIncluding primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
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and the median ICU and hospital stay were 2.5 (1–88) and
23.5 (11–174) days, respectively. ICU and hospital stay
was longer for patients at the lowest L3-PMI [n = 2, median
ICU stay: 55.5 (23–88) days; median hospital stay: 151
(128–174) days] compared with the other L3-PMI quartiles
[median ICU stay: 2 (1–5) days, P = 0.034; median hospital
stay: 22.5 (1–34) days, P = 0.036], while the incidence of
infections was also higher (100% vs. 12.5%, P = 0.016). The
MELD score of the patients at the lowest L3-PMI did not
signiﬁcantly differ from that of patients from the other
L3-PMI quartiles (15 vs. 18). Six of 7 (85.7%) patients with
available RFH-GA were moderately/severely malnourished
therefore no meaningful comparisons could be performed.
Discussion
The identiﬁcation of patients listed for LT that are susceptible
to increased post-operative morbidity and mortality is pivotal
in order to optimize candidate selection, organ allocation and
optimal graft-to-recipient matching. Malnutrition and sarco-
penia are well-recognized predictors of pre-LT morbidity and
mortality;12,16 indeed, nutritional status was one of the com-
ponents of the original Child–Pugh score,28 implicating that
its impact on patients with end-stage liver disease is well
recognized for a long time. In this study, we have shown that
both are independent predictors of longer mechanical
Figure 1 Box plots of L3-psoas muscle index (L3-PMI) for male and female
patients stratiﬁed according to Royal Free Hospital-Global Assessment
(RFH-GA). Males well-nourished: median PMI = 492.7 (range 224.2–
856.1), mild/moderately malnourished: median PMI = 399.05.4 (187.3–
648.7), severely malnourished: median PMI = 313.5 (195.8–454.9).
Females well-nourished: median PMI = 388.8 (range 210.4–763.8), mild/
moderately malnourished: median PMI = 309.4 (78.9–589.9), severely
malnourished: median PMI = 317.65 (215.8–508.1).
Figure 2 Box-plots of L3-psoas muscle index (L3-PMI) for male and
female patients stratiﬁed according to Model for End-stage Liver Disease
(MELD). Males: median L3-PMI levels were 486.6 (range 200.8–856.1),
417.6 (178.9–817.3), 415.15 (236.7–806.2), 335.6 (187.3–536.2), and
483.2 (162.5–983) mm2/m2 for MELD score ≤10, 11–15, 16–20, 21–25,
and >25, respectively. Females: median L3-PMI levels were 370.5 (range
78.9–554.6), 330.75 (135.4–589.9), 368.3 (150.5–763.8), 308 (205.4–
392.3), and 359.9 (215.8–394.9) mm2/m2 for MELD score ≤10, 11–15,
16–20, 21–25, and >25, respectively.
Figure 3 Nutritional status of the transplant recipients assessed by Royal
Free Hospital-Global Assessment (RFH-GA) stratiﬁed according to Model
for End-stage Liver Disease (MELD) score.
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ventilation, longer ICU and hospital stay, increased incidence
of infections, and of 12month mortality post-LT.
We analysed separately malnutrition and sarcopenia, in
order to ascertain their relative inﬂuence in such outcomes.
When analysing sarcopenia, we have chosen the cross-
sectional area of the psoas muscle because it is easy to
measure, more generalizable, with no need for computation
and, thus, simpler to use in clinical practice compared with
the skeletal muscle cross-sectional area, which includes all
surrounding muscles in the L3 region. Psoas muscle is not
easily affected by abdominal distention in cases of ascites
and has been shown to be predictive of mortality in cirrhosis
both before and after transplantation.16,24 Furthermore, we
used RFH-GA, which is a composite score that takes into
account both nutritional status and sarcopenia and links
nutrition with functional muscle mass in a given individual.
Few studies have looked at the effect of sarcopenia in post-
LT outcomes, and all had important limiting factors in the anal-
ysis, while no study has analysed the nutritional status of the
patients. Compared with these studies,18,19 we evaluated do-
nor and graft characteristics such as suboptimal graft appear-
ance, CIT and type of grafts, which are known predictors of
poor early post-LT outcome29,30 and we included a wide range
of clinically relevant outcomes including post-transplant mor-
tality. In a retrospective cohort of 245 patients,19 the effect of
sarcopenia on the length of hospital stay was not tested in a
multivariate analysis with other known predictive factors such
as liver disease severity, whereas the cut-offs used for the
deﬁnition of sarcopenia have not been validated in patients
with cirrhosis.13 In another study, only post-transplant infec-
tions were analysed as an endpoint.18
The results of our study have important implications for
graft-recipient matching but also for optimizing patients’
nutrition while on the transplant waiting list. First, we
showed that patients with muscle depletion or malnutrition
who received a steatotic liver graft with prolonged CIT
(>12h) had a signiﬁcantly longer ICU and hospital stay and a
higher rate of infections despite similar MELD scores, implying
the need for allocation of more optimal grafts in malnourished
patients with sarcopenia.
Second, we showed that sarcopenia and malnutrition are
not reﬂected in the MELD score, as they showed a wide over-
lap of values across different MELD scores. Although MELD
consists of objective variables, it has certain limitations that
could lead to misclassiﬁcation of some patients.31 Considering
that malnutrition is a common feature in advanced cirrhosis,
as reﬂected in our study and others,2 an objective, cost-
effective, easy to administer, and well-validated marker of nu-
tritional status is needed to enhance the c-statistic of MELD
score. RFH-GA has the advantages of lower cost, and higher
availability and reproducibility compared with CT muscle mea-
surements,11 whereas the latter provides an objective and
quantitative muscle mass assessment.14 Therefore, the poten-
tial effect of both scores on enhancing the discrimination and
calibration ability of MELD should be further investigated.
Third, we showed for the ﬁrst time the importance of RFH-
GA in determining post-LT outcomes. RFH-GA is considered a
‘nutritional review’ and provides a valid assessment of nutri-
tional status in patients with cirrhosis.11 In such patients, poor
nutritional status as assessed by RFH-GA, is associated with
worse survival independently of the severity of liver disease
as assessed by prognostic scores,11 and adds signiﬁcantly to
the predictive accuracy of both Child–Pugh and MELD score.12
In the present study, pre-transplant malnutrition predicted
post-LT outcomes independently of the severity of liver
disease and other established predictive factors. Despite the
Table 2 Multivariate analysis of factors associated with post-transplant outcomes
OR (95% CI) P value
Factors Multivariate analysis for in-hospital infections
MELD score, median (range) 1.055 (1.002–1.11) 0.041
RFH-GA category 3, n (%)a 6.55 (1.99–21.5) 0.011
MV duration >24 h
MELD score, median (range) 1.1 (1.036–1.168) 0.002
RFH-GA category 3, n (%)a 8.5 (1.48–48.87) 0.016
Suboptimal donor liver, n (%) 2.326 (1.056–5.12) 0.036
ICU stay >5 days
Age (years), median (range) 1.054 (1.004–1.106) 0.033
MELD score, median (range) 1.137 (1.057–1.223) 0.001
RFH-GA category 3, n (%)a 7.46 (1.57–35.43) 0.004
Hospital stay >20 days
Male sex, n (%) 2.107 (1.004–4.419) 0.049
L3-PMI (mm2/m2), median (range) 0.996 (0.994–0.999) 0.006
12month mortality
L3-PMI (mm2/m2), median (range) 0.996 (0.992–0.999) 0.05
CI, conﬁdence interval; L3-PMI, psoas muscle index; MV, mechanical ventilation; OR, odds ratio; MELD, model for end-stage liver disease;
RFH-GA, Royal Free Hospital global assessment.
aReference category: RFH-SGA category 1 (well nourished).
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strong correlation between them, RFH-GA was better than
psoas muscle mass measurement in predicting post-LT in-
hospital infections and ICU stay. Therefore these emphasize
the critical need for pre-operative assessment of nutritional sta-
tus in all LT candidates and also for the potential development and
validation of a tool to predict post-transplant outcomes. The cur-
rent results could be regarded as a proof of concept that
malnutrition/sarcopenia should be part of this tool.
Pre-LT malnutrition/sarcopenia, although not easily, could
be potentially modiﬁable. The effect of pre-LT nutritional sup-
plementation on modifying the nutritional status of these pa-
tients and, subsequently, improving post-LT outcomes and
resource utilization should be elucidated, preferably in random-
ized controlled studies. Moreover, it seems that the combina-
tion of simple anthropometric measures (BMI and MAMC)
together with the evaluation of dietary intake (all used in the
RFH-GA assessment) can efﬁciently predict signiﬁcant post-LT
outcomes and might have higher predictive discrimination than
CT muscle mass measurements. On the other hand, despite the
observed strong association between RFH-GA and TPA, we
found that malnourished patients demonstrate a wide range
of PMI values, implying that not all patients classiﬁed as mal-
nourished with RFH-GA have sarcopenia.
We evaluated the potential impact of gender on outcomes
considering, ﬁrst, the gender differences in body composition
parameters and, second, reports32 on the higher cumulative
survival rates of women with cirrhosis compared with male
patients. Our ﬁndings suggest that male gender is a con-
founding factor for both psoas muscle cross-sectional area
and RFH-GA, and that it was independently associated with
prolonged hospital stay and time on mechanical ventilation.
A potential explanation is that malnutrition in male patients
with cirrhosis is characterized mainly by muscle mass loss,
whereas in women by fat loss.11,33 It is therefore presumed
that males might have worse post-LT outcomes compared
with females because of less muscle mass in cases of malnu-
trition; however, this needs to be further elucidated.
This study must be considered within the context of its lim-
itations as it reports on a relative small sample size of a single-
centre experience and it has a retrospective design. However,
it is unlikely that our ﬁndings are because of type I error. Fur-
thermore, the sample size of patients receiving marginal
grafts is very small, and the results should be interpreted
with caution until conﬁrmed in larger series. Finally, the ma-
jority of our patient population had relatively low MELD
scores (<20), which is because of the centre-based allocation
and also to a different allocation score that is used in the UK.
However, we believe that these ﬁndings will be even more
pronounced in patients with worse liver dysfunction.
In conclusion, nutritional indices and sarcopenia are sig-
niﬁcantly associated with post-LT outcomes; therefore, mal-
nourished and/or sarcopenic patients need to be identiﬁed
pre-operatively for targeted nutritional interventions in order
to optimize liver transplantation outcomes and reduce associ-
ated costs.34 CT psoas muscle mass measurement is a reliable
and objective marker of nutritional status and fairly simple to
compute. RFH-GA, although subjective, is a simple bedside test
and is a better predictor of post-LT outcomes. A major implica-
tion of the present study is the need to avoid marginal grafts in
patients with sarcopenia irrespective of their MELD score.
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